A retrospective study assessing pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave
Latest Information Update: 24 Jun 2022
At a glance
- Drugs Cilgavimab/tixagevimab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 24 Jun 2022 New trial record
- 12 Jun 2022 Results published in the American Journal of Transplantation